Guadecitabine Extension Study
Clinical trial NCT03603964 · TERMINATED
Trial details
- NCT number
- NCT03603964
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-18
- Primary completion
- 2021-10-04
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.